4//SEC Filing
Vida Ventures, LLC 4
Accession 0000950170-24-015479
CIK 0001994702other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 7:04 PM ET
Size
21.8 KB
Accession
0000950170-24-015479
Insider Transaction Report
Form 4
Vida Ventures, LLC
10% Owner
Transactions
- Conversion
Common Stock
2024-02-12+4,523,924→ 4,523,924 total(indirect: By LLC) - Purchase
Common Stock
2024-02-12$22.00/sh+252,553$5,556,166→ 252,553 total(indirect: By Vida Ventures III, L.P.) - Purchase
Common Stock
2024-02-12$22.00/sh+583$12,826→ 583 total(indirect: By Vida Ventures III-A, L.P.) - Conversion
Series A-1 Redeemable Convertible Preferred Stock
2024-02-12−4,401,771→ 0 total(indirect: By LLC)→ Common Stock (967,188 underlying) - Conversion
Series A-2 Redeemable Convertible Preferred Stock
2024-02-12−8,830,901→ 0 total(indirect: By LLC)→ Common Stock (1,940,388 underlying) - Conversion
Series B Redeemable Convertible Preferred Stock
2024-02-12−7,356,162→ 0 total(indirect: By LLC)→ Common Stock (1,616,348 underlying)
Vida Ventures GP III, L.L.C.
10% Owner
Transactions
- Conversion
Common Stock
2024-02-12+4,523,924→ 4,523,924 total(indirect: By LLC) - Purchase
Common Stock
2024-02-12$22.00/sh+252,553$5,556,166→ 252,553 total(indirect: By Vida Ventures III, L.P.) - Purchase
Common Stock
2024-02-12$22.00/sh+583$12,826→ 583 total(indirect: By Vida Ventures III-A, L.P.) - Conversion
Series A-1 Redeemable Convertible Preferred Stock
2024-02-12−4,401,771→ 0 total(indirect: By LLC)→ Common Stock (967,188 underlying) - Conversion
Series A-2 Redeemable Convertible Preferred Stock
2024-02-12−8,830,901→ 0 total(indirect: By LLC)→ Common Stock (1,940,388 underlying) - Conversion
Series B Redeemable Convertible Preferred Stock
2024-02-12−7,356,162→ 0 total(indirect: By LLC)→ Common Stock (1,616,348 underlying)
Vida Ventures III, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2024-02-12+4,523,924→ 4,523,924 total(indirect: By LLC) - Purchase
Common Stock
2024-02-12$22.00/sh+252,553$5,556,166→ 252,553 total(indirect: By Vida Ventures III, L.P.) - Purchase
Common Stock
2024-02-12$22.00/sh+583$12,826→ 583 total(indirect: By Vida Ventures III-A, L.P.) - Conversion
Series A-1 Redeemable Convertible Preferred Stock
2024-02-12−4,401,771→ 0 total(indirect: By LLC)→ Common Stock (967,188 underlying) - Conversion
Series A-2 Redeemable Convertible Preferred Stock
2024-02-12−8,830,901→ 0 total(indirect: By LLC)→ Common Stock (1,940,388 underlying) - Conversion
Series B Redeemable Convertible Preferred Stock
2024-02-12−7,356,162→ 0 total(indirect: By LLC)→ Common Stock (1,616,348 underlying)
Vida Ventures III-A, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2024-02-12+4,523,924→ 4,523,924 total(indirect: By LLC) - Purchase
Common Stock
2024-02-12$22.00/sh+252,553$5,556,166→ 252,553 total(indirect: By Vida Ventures III, L.P.) - Purchase
Common Stock
2024-02-12$22.00/sh+583$12,826→ 583 total(indirect: By Vida Ventures III-A, L.P.) - Conversion
Series A-1 Redeemable Convertible Preferred Stock
2024-02-12−4,401,771→ 0 total(indirect: By LLC)→ Common Stock (967,188 underlying) - Conversion
Series A-2 Redeemable Convertible Preferred Stock
2024-02-12−8,830,901→ 0 total(indirect: By LLC)→ Common Stock (1,940,388 underlying) - Conversion
Series B Redeemable Convertible Preferred Stock
2024-02-12−7,356,162→ 0 total(indirect: By LLC)→ Common Stock (1,616,348 underlying)
Footnotes (5)
- [F1]Represents shares of the Issuer's Common Stock received upon conversion of shares of the reported series of preferred stock on a 1-for-4.5511 basis without payment of further consideration.
- [F2]The shares of the Issuer's Common Stock are held directly by Vida Ventures, LLC. Vida Ventures Advisors, LLC is the investment advisor to Vida Ventures, LLC. Dr. Arie Belldegrun, Leonard Potter and Dr. Fred E. Cohen, a member of the Issuer's board of directors, are the managing members of Vida Ventures Advisors, LLC, and may be deemed to share voting and dispositive power over the shares held by Vida Ventures, LLC, but each disclaims beneficial ownership of the shares held by Vida Ventures, LLC, except to the extent of such person's pecuniary interest therein, if any.
- [F3]The shares of the Issuer's Common Stock are held directly by Vida Ventures III, L.P. ("Vida III"). Vida Ventures GP III, L.L.C. ("Vida III GP") is the general partner of Vida III. Vida III GP disclaims beneficial ownership of the securities held by Vida III, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their pecuniary interest therein, if any.
- [F4]The shares of the Issuer's Common Stock are held directly by Vida Ventures III-A, L.P. ("Vida III-A"). Vida III GP is the general partner of Vida III-A. Vida III GP disclaims beneficial ownership of the securities held by Vida III-A, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their pecuniary interest therein, if any.
- [F5]The Series A-1, Series A-2 and Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 1-for-4.5511 basis immediately prior to the closing of the Issuer's initial public offering.
Documents
Issuer
Kyverna Therapeutics, Inc.
CIK 0001994702
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001724489
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 7:04 PM ET
- Size
- 21.8 KB